ILLUMINA
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and ... prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. David R. Walt, Satnam Alag, Larry Bock, and John Stuelpnagel co-founded Illumina in San Diego, California in 1998.
ILLUMINA
Industry:
Biotechnology Genetics Health Care Medical
Founded:
1998-01-01
Status:
Active
Contact:
858.202.4500
Email Addresses:
[email protected]
Total Funding:
28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Apache
Similar Organizations
Aegis Sciences
A forensic toxicology and health care sciences laboratory.
ArmaGen Technologies
ArmaGen is focused on developing technologies for siRNA delivery across the blood-brain barrier.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Celixir
Celixir is a unique technology platform drives in-house discovery and manufacturing.
Crystalplex
Crystalplex provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets.
Cynvec
Cynvec is a biotechnology company that develops a proprietary oncolytic technology for the treatment of cancer.
Genetic Technologies
Genetic Technologies is a molecular diagnostics company specializing in oncology.
Goodwin Biotechnology, Inc.
Goodwin Biotechnology is a biotechnology company that offers biologics process development and purification bioconjugation services.
Lasergen
Lasergen is a biotechnology company developing and commercializing technologies for genomic applications.
LifeWave
LifeWave focuses on developing non-invasive and sensing technology for prenatal and neonatal monitoring in clinical and remote settings.
Naviscan
Naviscan develops a high-resolution PET scanner that provides unprecedented visualization of small body parts.
NextCare
NextCare offers urgent care and occupational medical services for various illnesses such as cough, diaper rashes, earaches and more.
PolarityTE
PolarityTE is revolutionary platform induces cell and tissue polarity, creating uniquely functional tissue.
Ravgen
Ravgen is a biotechnology company that specializes in non-invasive prenatal diagnostic testing.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-06-28 | IDbyDNA | IDbyDNA acquired by Illumina | N/A |
| 2020-09-21 | Grail | Grail acquired by Illumina | 8 B USD |
| 2020-07-14 | Enancio | Enancio acquired by Illumina | N/A |
| 2020-06-17 | Bluebee | Bluebee acquired by Illumina | N/A |
| 2018-05-15 | Edico Genome | Edico Genome acquired by Illumina | 100 M USD |
| 2016-01-27 | Conexio Genomics | Conexio Genomics acquired by Illumina | N/A |
| 2015-08-04 | GenoLogics | GenoLogics acquired by Illumina | N/A |
| 2013-10-28 | NextBio | NextBio acquired by Illumina | N/A |
| 2013-07-23 | Advanced Liquid Logic | Advanced Liquid Logic acquired by Illumina | 96 M USD |
| 2013-01-08 | Moleculo | Moleculo acquired by Illumina | N/A |
Investors List
CW Group
CW Group investment in Venture Round - Illumina
Venrock
Venrock investment in Venture Round - Illumina
Lombard Odier
Lombard Odier investment in Venture Round - Illumina
Chevron Technology Ventures
Chevron Technology Ventures investment in Venture Round - Illumina
The Dow Chemical Company
The Dow Chemical Company investment in Venture Round - Illumina
Chase Capital Partners
Chase Capital Partners investment in Venture Round - Illumina
ARCH Venture Partners
ARCH Venture Partners investment in Venture Round - Illumina
Tredegar Investments
Tredegar Investments investment in Venture Round - Illumina
State Farm Insurance
State Farm Insurance investment in Venture Round - Illumina
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | Mable (Neurolytic Healthcare) | Illumina investment in Pre Seed Round - Mable (Neurolytic Healthcare) | N/A |
| 2021-09-01 | SomaLogic | Illumina investment in Post-IPO Equity - SomaLogic | 375 M USD |
| 2021-04-01 | Concr | Illumina investment in Seed Round - Concr | 499.84 K GBP |
| 2020-05-28 | Ginkgo Bioworks | Illumina investment in Series F - Ginkgo Bioworks | 70 M USD |
| 2020-05-06 | Grail | Illumina investment in Series D - Grail | 390 M USD |
| 2018-03-01 | Helixis | Illumina investment in Venture Round - Helixis | 200 M USD |
| 2018-03-01 | Helix | Illumina investment in Series B - Helix | 200 M USD |
| 2016-11-15 | Prospect Bio | Illumina investment in Seed Round - Prospect Bio | 2.8 M USD |
| 2016-02-17 | Vitagene | Illumina investment in Seed Round - Vitagene | 2 M USD |
| 2016-01-12 | Grail | Illumina investment in Series A - Grail | 100 M USD |
Newest Events participated
Participated in Rock Health Summit
on 2015-09-29 as exhibitor
Key Employee Changes
More informations about "Illumina"
Illumina, Inc. - Wikipedia
Illumina was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee. While working with CW Group, a venture-capital firm, Bock and Stuelpnagel uncovered what would become Illumina's BeadArray technology at Tufts University and negotiated an exclusive license to that technology. In 1999, Illumina acquired Spyder Instruments (founded by M…See details»
About Us | A global leader in genomics - Illumina
In 2022, Illumina technology drove over 300,000 studies featured in peer-reviewed scientific publications—and we are just getting started. From pathogen surveillance in Africa, to global …See details»
Illumina - LinkedIn
Illumina | 501,542 followers on LinkedIn. Unlocking the Power of the Genome | At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic ...See details»
25 greatest impacts in 25 years: Illumina and the evolution of …
Illumina Is One of the 2021 TIME100 Most Influential …
Apr 27, 2021 Illumina is a child of the genetic revolution launched in the late 1990s during the breathless run-up to scientists’ publishing the first draft map of the human genome in 2001.See details»
Illumina | World Economic Forum
The World Economic Forum is an independent international organization committed to improving the state of the world by engaging business, political, academic and other leaders of society to …See details»
Illumina and Genetic Alliance Launch $120 Million Global Initiative …
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based …See details»
Illumina | Sequencing and array solutions to fuel …
Nov 20, 2024 At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver …See details»
Illumina - MIT Technology Review
Feb 18, 2014 Illumina was relentless in getting to this point. When CEO Jay Flatley joined the company in 1999, it was a 25–person startup that sold microarray chips, which were useful in examining specific ...See details»
Board of Directors - Illumina
Illumina Proactive Instrument Performance Service. ... a 2,400 person global research organization focused on conducting personalized medicine, health economics, drug safety, outcomes, and comparative effectiveness research …See details»
Illumina, Inc. - Illumina and Genetic Alliance Launch $120 Million ...
SAN DIEGO, Nov. 16, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) and Genetic Alliance today announced the creation of the iHope ™ Genetic Health program aimed at providing …See details»
Illumina, Inc. - Investors
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is …See details»
Illumina Commits to Net Zero Global Greenhouse Gas Emissions …
Illumina also joins the United Nations "Race to Zero" campaign in the run-up to the 26 th UN Climate Change Conference of the Parties (COP26) and underlines Illumina's commitment to …See details»
People | We nurture our people through a culture of care - Illumina
Development at Illumina is an intentional, everyday activity that prepares employees for success in their work now and for opportunities in the future. It is available to all, accessible in many …See details»
Illumina, Inc. (ILMN) - Yahoo Finance Canada
It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library …See details»
Illumina Supports Canada's Nationwide COVID-19 Genome …
SAN DIEGO, Nov. 3, 2021 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) today announced that its world-class sequencing and bioinformatics solutions are being used by HostSeq, part of the …See details»
The Bioinformatic Applications of Hi-C and Linked Reads - Oxford …
Jun 21, 2024 Hi-C is the culmination of several generations of chromosome conformation capture technologies, which probes the spatial organization of chromatin within a cell at a …See details»
Corporate and Social Responsibility | Illumina CSR Report
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is …See details»
Illumina CTO: Fueling Innovation, Inventing the Future - WSJ
Feb 4, 2022 Resting on that recent accomplishment is not an option, according to Aravanis. Illumina plans to maintain a pipeline of new products and capabilities to meet the evolving …See details»
Applications of whole-genome sequencing in hematologic …
5 days ago Research on cancers such as acute myeloid leukemia, myelodysplastic syndrome, myeloma, and chronic lymphocytic leukemia has led to major improvements in personalized …See details»